![](/img/cover-not-exists.png)
De-escalation of infliximab maintenance therapy from 8- to 10-week dosing interval based on fecal calprotectin in patients with Crohn’s disease
Papamichael, Konstantinos, Karatzas, Pantelis, Mantzaris, Gerassimos J.Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjv206
Date:
November, 2015
File:
PDF, 2.13 MB
english, 2015